Literature DB >> 35969780

Differential effects of Wnt-β-catenin signaling in Purkinje cells and Bergmann glia in spinocerebellar ataxia type 1.

Kimberly Luttik1,2, Leon Tejwani1,2, Hyoungseok Ju3, Terri Driessen3, Cleo J L M Smeets3, Chandrakanth Reddy Edamakanti4, Aryaan Khan5, Joy Yun5, Puneet Opal4, Janghoo Lim1,2,3,6,7.   

Abstract

Spinocerebellar ataxia type 1 (SCA1) is a dominantly inherited neurodegenerative disease characterized by progressive ataxia and degeneration of specific neuronal populations, including Purkinje cells (PCs) in the cerebellum. Previous studies have demonstrated a critical role for various evolutionarily conserved signaling pathways in cerebellar patterning, such as the Wnt-β-catenin pathway; however, the roles of these pathways in adult cerebellar function and cerebellar neurodegeneration are largely unknown. In this study, we found that Wnt-β-catenin signaling activity was progressively enhanced in multiple cell types in the adult SCA1 mouse cerebellum, and that activation of this signaling occurs in an ataxin-1 polyglutamine (polyQ) expansion-dependent manner. Genetic manipulation of the Wnt-β-catenin signaling pathway in specific cerebellar cell populations revealed that activation of Wnt-β-catenin signaling in PCs alone was not sufficient to induce SCA1-like phenotypes, while its activation in astrocytes, including Bergmann glia (BG), resulted in gliosis and disrupted BG localization, which was replicated in SCA1 mouse models. Our studies identify a mechanism in which polyQ-expanded ataxin-1 positively regulates Wnt-β-catenin signaling and demonstrate that different cell types have distinct responses to the enhanced Wnt-β-catenin signaling in the SCA1 cerebellum, underscoring an important role of BG in SCA1 pathogenesis.

Entities:  

Keywords:  Bergmann glia; Purkinje cells; Wnt-β-catenin signaling; neurodegeneration; spinocerebellar ataxia type 1

Mesh:

Substances:

Year:  2022        PMID: 35969780      PMCID: PMC9407543          DOI: 10.1073/pnas.2208513119

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   12.779


  67 in total

1.  Developmental expression of Wnt signaling factors in mouse brain.

Authors:  Jacquelyn Coyle-Rink; Luis Del Valle; Thersa Sweet; Kamel Khalili; Shohreh Amini
Journal:  Cancer Biol Ther       Date:  2002 Nov-Dec       Impact factor: 4.742

2.  Decreased expression of glutamate transporter GLAST in Bergmann glia is associated with the loss of Purkinje neurons in the spinocerebellar ataxia type 1.

Authors:  Marija Cvetanovic
Journal:  Cerebellum       Date:  2015-02       Impact factor: 3.847

3.  Bergmann glia expression of polyglutamine-expanded ataxin-7 produces neurodegeneration by impairing glutamate transport.

Authors:  Sara K Custer; Gwenn A Garden; Nishi Gill; Udo Rueb; Randell T Libby; Christian Schultz; Stephan J Guyenet; Thomas Deller; Lesnick E Westrum; Bryce L Sopher; Albert R La Spada
Journal:  Nat Neurosci       Date:  2006-08-27       Impact factor: 24.884

4.  Low cancer prevalence in polyglutamine expansion diseases.

Authors:  Giulia Coarelli; Alhassane Diallo; Morgane Sonia Thion; Daisy Rinaldi; Fabienne Calvas; Ouahid Lagha Boukbiza; Alina Tataru; Perrine Charles; Christine Tranchant; Cecilia Marelli; Claire Ewenczyk; Maya Tchikviladzé; Marie-Lorraine Monin; Bertrand Carlander; Mathieu Anheim; Alexis Brice; Fanny Mochel; Sophie Tezenas du Montcel; Sandrine Humbert; Alexandra Durr
Journal:  Neurology       Date:  2017-02-15       Impact factor: 9.910

5.  Expansion of an unstable trinucleotide CAG repeat in spinocerebellar ataxia type 1.

Authors:  H T Orr; M Y Chung; S Banfi; T J Kwiatkowski; A Servadio; A L Beaudet; A E McCall; L A Duvick; L P Ranum; H Y Zoghbi
Journal:  Nat Genet       Date:  1993-07       Impact factor: 38.330

6.  A long CAG repeat in the mouse Sca1 locus replicates SCA1 features and reveals the impact of protein solubility on selective neurodegeneration.

Authors:  Kei Watase; Edwin J Weeber; Bisong Xu; Barbara Antalffy; Lisa Yuva-Paylor; Kouichi Hashimoto; Masanobu Kano; Richard Atkinson; Yaling Sun; Dawna L Armstrong; J David Sweatt; Harry T Orr; Richard Paylor; Huda Y Zoghbi
Journal:  Neuron       Date:  2002-06-13       Impact factor: 17.173

Review 7.  Pathogenic mechanisms underlying spinocerebellar ataxia type 1.

Authors:  Leon Tejwani; Janghoo Lim
Journal:  Cell Mol Life Sci       Date:  2020-04-18       Impact factor: 9.261

Review 8.  Trinucleotide Repeat Expansion Diseases, RNAi, and Cancer.

Authors:  Andrea E Murmann; Jindan Yu; Puneet Opal; Marcus E Peter
Journal:  Trends Cancer       Date:  2018-09-26

Review 9.  Crosstalk between Wnt/β-Catenin and NF-κB Signaling Pathway during Inflammation.

Authors:  Bin Ma; Michael O Hottiger
Journal:  Front Immunol       Date:  2016-09-22       Impact factor: 7.561

10.  Molecular pathway analysis towards understanding tissue vulnerability in spinocerebellar ataxia type 1.

Authors:  Terri M Driessen; Paul J Lee; Janghoo Lim
Journal:  Elife       Date:  2018-12-03       Impact factor: 8.140

View more
  1 in total

1.  Identifying Disease Signatures in the Spinocerebellar Ataxia Type 1 Mouse Cortex.

Authors:  Kimberly Luttik; Victor Olmos; Ashley Owens; Aryaan Khan; Joy Yun; Terri Driessen; Janghoo Lim
Journal:  Cells       Date:  2022-08-24       Impact factor: 7.666

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.